Biosimilar Market to Expand Steadily with CAGR of 18.32%, Targeting $125.32 Billion by 2034
Biosimilar Market Overview 2024-2034
Biosimilar Market Growth is expected to grow at a compound annual growth rate (CAGR) of 18.32% between 2024 and 2034, reaching an estimated value of USD 125.32 billion by the end of the forecast period. In 2024, the market is projected to be valued at USD 27.46 billion.
What Are Biosimilars?